中高位直肠癌的手术现状及研究进展OA
Current status and research progress of surgery for middle and high rectal cancer
直肠癌是常见的消化道恶性肿瘤,其诊疗策略高度依赖于肿瘤的精准定位.基于直肠分段原则,临床上将直肠癌划分为超低位、低位、中位和高位,不同分段的肿瘤在手术方式、淋巴结清扫范围、神经功能保护以及是否需行新辅助治疗等方面存在差异.长期以来,低位直肠癌(特别是涉及肛管括约肌和保肛问题的超低位直肠癌)是临床研究与争议的焦点.然而,随着全直肠系膜切除术(TME)原则的普及、微创技术的革新以及"全程新辅助治疗"模式的出现,中高位直肠癌的诊疗理念也在不断更新与优化.本文旨在系统阐述直肠癌的划分原则与具体方法,并重点聚焦于中高位直肠癌的手术治疗现状,深入探讨其在微创手术、功能保护、个体化治疗及联合脏器切除等前沿领域的研究进展,以期为临床实践提供参考.
Rectal cancer is a common malignant tumor of the digestive tract,and its diagnosis and treatment strategies are highly dependent on the accurate localization of the tumor.Based on rectal anatomical segmentation principles,rectal cancer is clinically classified into ultra-low,low,middle,and high subtypes.Tumors at different segments show significant differences in surgical approaches,the scope of lymph node dissection,neurological function protection,and the indications for neoadjuvant therapy.For a long time,low rectal cancer,espe-cially ultra-low rectal cancer involving the anal sphincter as well as sphincter preservation,has been the focus of clinical research and con troversy.However,with the popularization of the principle of total mesorectal excision(TME),the innovation of minimally invasive techniques,and the emergence of the total neoadjuvant therapy model,the concept of diagnosis and treatment for middle and high rectal cancer is con stantly updated and optimized.This article aims to systematically elaborate on the principles and specific methods of rectal cancer classifica-tion,focus on the current status of surgical treatment for middle and high rectal cancer,and deeply explore the research progress in cutting-edge fields such as minimally invasive surgery,functional protection,individualized treatment,and combined organ resection,so as to provide a reference for clinical practice.
李朝明;梁桃军;巩进伟;余伦
陇南市第一人民医院,甘肃 陇南 746000陇南市第一人民医院,甘肃 陇南 746000陇南市第一人民医院,甘肃 陇南 746000陇南市第一人民医院,甘肃 陇南 746000
医药卫生
中高位直肠癌全直肠系膜切除术微创手术器官保留新辅助治疗
middle and high rectal cancertotal mesorectal excisionminimally invasive surgeryorgan preservationneoadjuvant therapy
《甘肃医药》 2026 (6)
484-488,5
陇南市强科技项目(编号:2023-S-QKJ-14)
评论